These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 10325957

  • 1. Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats.
    Richer C, Fornes P, Cazaubon C, Domergue V, Nisato D, Giudicelli JF.
    Cardiovasc Res; 1999 Jan; 41(1):100-8. PubMed ID: 10325957
    [Abstract] [Full Text] [Related]

  • 2. Effects of angiotensin II AT1-receptor blockade on coronary dynamics, function, and structure in postischemic heart failure in rats.
    Gervais M, Fornes P, Richer C, Nisato D, Giudicelli JF.
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):329-37. PubMed ID: 10975590
    [Abstract] [Full Text] [Related]

  • 3. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D, Galuppo P, Schmidt I, Ertl G, Bauersachs J.
    Cardiovasc Res; 2005 Jul 01; 67(1):97-105. PubMed ID: 15949473
    [Abstract] [Full Text] [Related]

  • 4. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H.
    Circulation; 1994 May 01; 89(5):2273-82. PubMed ID: 8181153
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle.
    Ambrose J, Pribnow DG, Giraud GD, Perkins KD, Muldoon L, Greenberg BH.
    J Cardiovasc Pharmacol; 1999 Mar 01; 33(3):433-9. PubMed ID: 10069680
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
    Spinale FG, Holzgrefe HH, Walker JD, Mukherjee R, Kribbs SB, Powell JR, Antonaccio M.
    J Cardiovasc Pharmacol; 1997 Nov 01; 30(5):623-31. PubMed ID: 9388045
    [Abstract] [Full Text] [Related]

  • 7. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure.
    Mulder P, Richard V, Bouchart F, Derumeaux G, Münter K, Thuillez C.
    Cardiovasc Res; 1998 Sep 01; 39(3):600-8. PubMed ID: 9861302
    [Abstract] [Full Text] [Related]

  • 8. AT1 receptor blockade prevents cardiac dysfunction after myocardial infarction in rats.
    Berthonneche C, Sulpice T, Tanguy S, O'Connor S, Herbert JM, Janiak P, de Leiris J, Boucher F.
    Cardiovasc Drugs Ther; 2005 Aug 01; 19(4):251-9. PubMed ID: 16193242
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure.
    Havranek EP, Thomas I, Smith WB, Ponce GA, Bilsker M, Munger MA, Wolf RA.
    J Am Coll Cardiol; 1999 Apr 01; 33(5):1174-81. PubMed ID: 10193713
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
    Carraway JW, Park S, McCune SA, Holycross BJ, Radin MJ.
    J Cardiovasc Pharmacol; 1999 Mar 01; 33(3):451-60. PubMed ID: 10069682
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure.
    Yoshida H, Takahashi M, Tanonaka K, Maki T, Nasa Y, Takeo S.
    Br J Pharmacol; 2001 Sep 01; 134(1):150-60. PubMed ID: 11522607
    [Abstract] [Full Text] [Related]

  • 15. Effects of differential blockade of the renin-angiotensin system in postinfarcted rats.
    Lacour C, Roccon A, Galindo G, Canals F, Hogie M, Segondy D, Briand D, Roque C, Herbert JM, Nisato D.
    Fundam Clin Pharmacol; 2004 Jun 01; 18(3):299-307. PubMed ID: 15147281
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT, Wiedmann RT, Greenland BD, Lynch JJ, Grossman W.
    Cardiovasc Res; 1998 Aug 01; 39(2):413-22. PubMed ID: 9798526
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO, Lee MA, Weigner M, Lindpaintner K, Bishop SP, Benedict CR, Ho KK, Douglas PS, Chafizadeh E, Lorell BH.
    Circulation; 1997 Mar 18; 95(6):1592-600. PubMed ID: 9118530
    [Abstract] [Full Text] [Related]

  • 19. Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism.
    Schäfer A, Fraccarollo D, Tas P, Schmidt I, Ertl G, Bauersachs J.
    Eur J Heart Fail; 2004 Mar 01; 6(2):151-9. PubMed ID: 14984722
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.